Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5–10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavi...

Full description

Bibliographic Details
Main Authors: Evanthia Thomaidou, Eleni Karlafti, Matthaios Didagelos, Kalliopi Megari, Eleni Argiriadou, Karolina Akinosoglou, Daniel Paramythiotis, Christos Savopoulos
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/16/3/455
_version_ 1797239033396461568
author Evanthia Thomaidou
Eleni Karlafti
Matthaios Didagelos
Kalliopi Megari
Eleni Argiriadou
Karolina Akinosoglou
Daniel Paramythiotis
Christos Savopoulos
author_facet Evanthia Thomaidou
Eleni Karlafti
Matthaios Didagelos
Kalliopi Megari
Eleni Argiriadou
Karolina Akinosoglou
Daniel Paramythiotis
Christos Savopoulos
author_sort Evanthia Thomaidou
collection DOAJ
description Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5–10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system. Acute cholecystitis has been reported in patients with COVID-19. The purpose of this review is to provide a detailed analysis of the current literature on the pathogenesis, diagnosis, management, and outcomes of AAC in patients with COVID-19.
first_indexed 2024-04-24T17:45:06Z
format Article
id doaj.art-7819c13a77cc478d9cb2d756a02ae9b3
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-04-24T17:45:06Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-7819c13a77cc478d9cb2d756a02ae9b32024-03-27T14:07:56ZengMDPI AGViruses1999-49152024-03-0116345510.3390/v16030455Acalculous Cholecystitis in COVID-19 Patients: A Narrative ReviewEvanthia Thomaidou0Eleni Karlafti1Matthaios Didagelos2Kalliopi Megari3Eleni Argiriadou4Karolina Akinosoglou5Daniel Paramythiotis6Christos Savopoulos7Department of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceEmergency Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceCITY College, University of York Europe Campus, 54626 Thessaloniki, GreeceDepartment of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceDepartment of Medicine, University General Hospital of Patras, 26504 Rio, GreeceFirst Propaedeutic Department of Surgery, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceFirst Propaedeutic Internal Medicine Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, GreeceAcute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5–10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system. Acute cholecystitis has been reported in patients with COVID-19. The purpose of this review is to provide a detailed analysis of the current literature on the pathogenesis, diagnosis, management, and outcomes of AAC in patients with COVID-19.https://www.mdpi.com/1999-4915/16/3/455acalculous cholecystitisgallbladderCOVIDSARS-CoV-2
spellingShingle Evanthia Thomaidou
Eleni Karlafti
Matthaios Didagelos
Kalliopi Megari
Eleni Argiriadou
Karolina Akinosoglou
Daniel Paramythiotis
Christos Savopoulos
Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
Viruses
acalculous cholecystitis
gallbladder
COVID
SARS-CoV-2
title Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
title_full Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
title_fullStr Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
title_full_unstemmed Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
title_short Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
title_sort acalculous cholecystitis in covid 19 patients a narrative review
topic acalculous cholecystitis
gallbladder
COVID
SARS-CoV-2
url https://www.mdpi.com/1999-4915/16/3/455
work_keys_str_mv AT evanthiathomaidou acalculouscholecystitisincovid19patientsanarrativereview
AT elenikarlafti acalculouscholecystitisincovid19patientsanarrativereview
AT matthaiosdidagelos acalculouscholecystitisincovid19patientsanarrativereview
AT kalliopimegari acalculouscholecystitisincovid19patientsanarrativereview
AT eleniargiriadou acalculouscholecystitisincovid19patientsanarrativereview
AT karolinaakinosoglou acalculouscholecystitisincovid19patientsanarrativereview
AT danielparamythiotis acalculouscholecystitisincovid19patientsanarrativereview
AT christossavopoulos acalculouscholecystitisincovid19patientsanarrativereview